Terkko Navigator / Cancer Letters

KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo

Exosome-mediated delivery of RNA and DNA for gene therapy

CircRNA in cancer: Fundamental mechanism and clinical potential

Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation

Androgen deprivation-induced elevated nuclear SIRT1 promotes prostate tumor cell survival by reactivation of AR signaling

Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair

Noncoding RNAs in osteosarcoma: Implications for drug resistance

Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma

Emerging biofabrication approaches for gastrointestinal organoids towards patient specific cancer models

Non-matrigel scaffolds for organoid cultures

Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis

Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapy

DIM-C-pPhtBu induces lysosomal dysfunction and unfolded protein response - mediated cell death via excessive mitophagy

Long non-coding RNA regulating androgen receptor signaling in breast and prostate cancer

Trials and tribulations of pancreatic cancer immunotherapy

Long noncoding RNA: A resident staff of genomic instability regulation in tumorigenesis

Immunization with alloantibodies-covered melanoma cells induces regional antitumor effects that become systemic when combined with 5-FU treatment

LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation

Inhibition of DHFR targets the self-renewing potential of brain tumor initiating cells

Interleukin-10 counteracts T-helper type 1 responses in B-cell lymphoma and is a target for tumor immunotherapy

MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans

p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma

Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis

Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth

The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies

Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis

Mortalin depletion induces MEK/ERK-dependent and ANT/CypD-mediated death in vemurafenib-resistant B-RafV600E melanoma cells

Long non-coding RNAs at work on telomeres: Functions and implications in cancer therapy

FBXL10 promotes ERRα protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRα

Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives

COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice

ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells

Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer

Angio-associated migratory cell protein (AAMP) interacts with cell division cycle 42 (CDC42) and enhances migration and invasion in human non-small cell lung cancer cells

LncRNAs in cancer: Regulatory and therapeutic implications

Splicing factors: Insights into their regulatory network in alternative splicing in cancer

Cancer-associated 53BP1 mutations induce DNA damage repair defects

Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer

The potential of long noncoding RNAs for precision medicine in human cancer

Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer

The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment

Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer

Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma

Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes

Helper T cells in malignant pleural effusion

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis

Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs

YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer

lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma

Corrigendum to “Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22” [Canc. Lett. 340 (1) (Oct 28, 2013) 72–81]